about
Signal transductions and nonalcoholic fatty liver: a mini-reviewStudying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyThe Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitisStem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice.Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury.Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out MiceInflammation and fibrogenesis in steatohepatitis.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.Liver fibrogenesis in non-alcoholic steatohepatitis.Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy.
P2860
Q26991757-6CF1443F-5295-4F72-BE6F-B4B20942A5C2Q27010291-969376E0-779D-42E6-A274-BB808CBBC870Q30382395-8D24A388-73D7-430C-9510-28E74FF51CF2Q34827887-716C2FAB-2D05-461A-8DB2-8DC2D347700AQ35086412-4663CDA8-EBD7-48CD-906C-007285E70E90Q35197524-9861BD2D-3F53-42BC-84EA-636ACE8C1D52Q35409945-469F1F95-92EF-4B6D-B32F-E08D72193C60Q35720450-02237374-87AA-4157-951E-FCDDFA3B2A03Q35753386-55CA8C97-EC07-493E-9AA6-8F535C92B7D8Q36376266-119844E0-78F7-40B7-94FC-86D8312EE530Q37981867-C6764306-F680-4D45-B8A4-C83F6BF91CE9Q38018841-E8CE58B3-011E-45D2-A7D5-6F40DA8B38D3Q38209324-5A806358-EC92-4092-A50F-E9D84809503FQ41704552-F3B847EF-B842-4976-902B-0160E897DBB5Q42321514-6BEFBFE3-4F31-4947-A80F-02152BE1185BQ50796857-2DA948D0-9AAF-4657-B8E2-91BF1EF47315
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fibrogenesis in nonalcoholic steatohepatitis.
@en
Fibrogenesis in nonalcoholic steatohepatitis.
@nl
type
label
Fibrogenesis in nonalcoholic steatohepatitis.
@en
Fibrogenesis in nonalcoholic steatohepatitis.
@nl
prefLabel
Fibrogenesis in nonalcoholic steatohepatitis.
@en
Fibrogenesis in nonalcoholic steatohepatitis.
@nl
P2860
P356
P1476
Fibrogenesis in nonalcoholic steatohepatitis.
@en
P2093
Gianluca Svegliati-Baroni
Samuele De Minicis
P2860
P304
P356
10.1586/EGH.11.28
P577
2011-04-01T00:00:00Z